The Latest Breaking News from biotechnology

10,000 genome project India: The Department of Biotechnology has officially announced the completion of the ‘10,000 genome’ project — an attempt to create a reference database of whole-genome sequences out of India

Robust government support coupled with rapid tech advancements is bolstering the biotech sector. Hence, investors eyeing growth might buy fundamentally solid biotech stocks Theratechnologies (THTX), Equillium (EQ), and BioMarin Pharmaceutical (BMRN), with massive growth potential. Read on.

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

Karnataka aims to boost biotechnology sector growth with improved fiscal incentives and policy, says Department Secretary Ekroop Caur.

Learn about the U.S.-China biotech rivalry as lawmakers debate restrictions on Chinese companies in this informative Associated Press report.

AI and biotechnology lead deep tech funding in India, material science gathering momentum in recent years, says the newly-released report by VC firm Ankur Capital.

The biotechnology industry is experiencing significant growth, fueled by government initiatives, rising investments and tech advancements. Therefore, it could be wise to consider fundamentally strong biotech stocks Shionogi & Co (SGIOY), Equillium (EQ), and BioMarin Pharmaceutical (BMRN), which are making major moves on wall street. Read more.

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, adaptability, and technological advancements, demonstrating resilience. So, let’s analyze the upside potential of popular biotech stocks Biogen (BIIB) and Moderna (MRNA).

With a wide range of applications across sectors, including health, agriculture, and industrial processing, rapid technological adoption, and government support, the biotech industry’s prospects appear promising. Thus, investors could consider buying biotech stocks Corcept Therapeutics (CORT), Jazz Pharmaceuticals (JAZZ), Incyte (INCY), and Exelixis (EXEL) for substantial gains. Read on….

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

The biotech industry is well-positioned for solid growth thanks to the increasing demand for effective treatments for chronic diseases, a rapidly aging population, the adoption of technologies like AI, and government initiatives. To capitalize on the biotech industry’s growth prospects, should one consider investing in biotech stocks Puma Biotechnology (PBYI),…